top of page
Cancer Vaccine Institute News


FDA Approval of First Plasmid DNA Immunotherapy Ignites Hope for STEMVAC
On October 30, the FDA granted accelerated approval to Voceryq, the first-ever plasmid DNA-based immunotherapy, developed by Inovio Pharmaceuticals. The treatment delivers two plasmids to help the immune system target cells infected with human papillomavirus (HPV), which are responsible for recurrent respiratory papillomatosis (RRP). The FDA’s approval marks an important milestone for DNA-based therapeutics and could help advance research in this field. Cancer Vaccine Institu

Sarah White
Nov 6


Clinical Trial Open for STEMVAC for Metastatic Triple-Negative Breast Cancer
Breast cancer is one of the most common cancers and the second leading cause of cancer-related death among women. While advances in targeted therapies have improved patient outcomes for several breast cancer subtypes, metastatic triple-negative breast cancer (TNBC) remains one of the most challenging forms of the disease to treat. Although immune checkpoint inhibitors (ICIs) combined with chemotherapy have improved survival for some patients with metastatic TNBC, this benefit

Sarah White
Oct 12


Dr. Nora Disis Discusses Cancer Vaccines to Treat and Prevent Breast Cancer on FOX 13
Dr. Nora Disis, Director of the Cancer Vaccine Institute (CVI), spoke with FOX 13’s Claire Anderson to share encouraging clinical trial results and discuss the growing promise of breast cancer vaccines. The CVI is developing breast cancer vaccines that can program the body’s own immune system to recognize and kill breast cancer cells. These immune cells are capable of remaining in the body for years, providing long-term protection from cancer coming back. Dr. Disis explains,

Sarah White
Oct 5


On the Cancer Research Frontier: Meera Suresh Takes Steps Toward Ovarian Cancer Prevention
On the Cancer Research Frontier is a series spotlighting the scientists, doctors, nurses, patients, and philanthropists at the Cancer Vaccine Institute. Join us in meeting the brilliant minds behind our cancer vaccines and immunotherapies as they share their professional journeys and personal stories. On the dance floor, Meera Suresh moves her body rhythmically to the lively percussion, her facial expressions sharp and focused. Her arms move in angular patterns to the beat wh

Sarah White
Sep 29


Dr. Disis Leads Review Article in JAMA on the Momentum Behind Cancer Vaccine Research
The Cancer Vaccine Institute (CVI) is proud to share a review article published today in the Journal of the American Medical Association (JAMA) that highlights how far the field of cancer vaccines has come and why it’s at a true tipping point. Decades of research have brought us to a moment where the essential pieces are finally in place: hundreds of tumor antigens identified, a clear understanding of the immune responses needed for cancer eradication, safe and effective vacc

Sarah White
Sep 21
Blog: Blog2
bottom of page
